A further potential clinical benefit of high-dose intravenous iron is to overcome the inhibition of gastrointestinal iron absorption induced by hepcidin in patients with anemia of chronic disease or other inflammatory conditions (28, 29). This evidence concerns the gene HAMP and anemia (phenotype).